14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury

Stem Cells and Development

Volumn 21, Issue 7, 2012, Pages 1187-1199

  Tian, Haibin ^a   Lu, Yan ^a   Shah, Shraddha P ^a   Wang, Quansheng ^a   Hong, Song ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14,21 DIHYDROXYDOCOSAHEXAENOIC ACID; BETA ACTIN; CASPASE 3; CREATININE; DOCOSAHEXAENOIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENDRITIC CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CAPSULE; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE; MACROPHAGE; MESENCHYMAL STEM CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CREATININE; DOCOSAHEXAENOIC ACIDS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; KIDNEY; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860137826     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0220     Document Type: Article

References (69)

1. Togel FE and C Westenfelder. (2010). Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol 6:179-183.
2. Haider H and M Ashraf. (2008). Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45:554-566.
3. Prockop DJ, DJ Kota, N Bazhanov and RL Reger. (2010). Evolving paradigms for repair of tissues by adult stem/ progenitor cells (MSCs). J Cell Mol Med 14:2190-2199.
4. Wang G, BA Bunnell, RG Painter, BC Quiniones, S Tom, NA Lanson, Jr., JL Spees, D Bertucci, A Peister, et al. (2005). Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 102:186-191.
5. Lange C, F Togel, H Ittrich, F Clayton, C Nolte-Ernsting, AR Zander and C Westenfelder. (2005). Administered mesenchymal stem cells enhance recovery from ischemia/ reperfusion-induced acute renal failure in rats. Kidney Int 68:1613-1617.
6. Togel F, A Cohen, P Zhang, Y Yang, Z Hu and C Westenfelder. (2009). Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 18:475-485.
7. Duffield JS, KM Park, LL Hsiao, VR Kelley, DT Scadden, T Ichimura and JV Bonventre. (2005). Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755.
8. Mias C, E Trouche, MH Seguelas, F Calcagno, F Dignat- George, F Sabatier, MD Piercecchi-Marti, L Daniel, P Bianchi, et al. (2008). Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26:1749-1757.
9. Hagiwara M, B Shen, L Chao and J Chao. (2008). Kallikreinmodified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 19:807-819.
10. Lee RH, MJ Seo, RL Reger, JL Spees, AA Pulin, SD Olson and DJ Prockop. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 103:17438-17443.
11. Poulsom R, SJ Forbes, K Hodivala-Dilke, E Ryan, S Wyles, S Navaratnarasah, R Jeffery, T Hunt, M Alison, et al. (2001). Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229-235.
12. Imasawa T, Y Utsunomiya, T Kawamura, Y Zhong, R Nagasawa, M Okabe, N Maruyama, T Hosoya and T Ohno. (2001). The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 12:1401-1409.
13. Rookmaaker MB, AM Smits, H Tolboom, K Van 't Wout, AC Martens, R Goldschmeding, JA Joles, AJ Van Zonneveld, HJ Grone, TJ Rabelink and MC Verhaar. (2003). Bone-marrowderived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 163:553-562.
14. Prodromidi EI, R Poulsom, R Jeffery, CA Roufosse, PJ Pollard, CD Pusey and HT Cook. (2006). Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24:2448-2455.
15. Togel F, Z Hu, K Weiss, J Isaac, C Lange and C Westenfelder. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42.
16. Horwitz EM and WR Prather. (2009). Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy. Isr Med Assoc J 11:209-211.
17. Iwatani H and E Imai. (2010). Kidney repair using stem cells: myth or reality as a therapeutic option? J Nephrol 23:143-146.
18. Imberti B, M Morigi, S Tomasoni, C Rota, D Corna, L Longaretti, D Rottoli, F Valsecchi, A Benigni, et al. (2007). Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921-2928.
19. Chen Y, H Qian,WZhu, X Zhang, Y Yan, S Ye, X Peng,WLi and W Xu. (2011). Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev 20:103-113.
20. Akcay A, Q Nguyen and CL Edelstein. (2009). Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009:137072.
21. Kinsey GR, L Li and MD Okusa. (2008). Inflammation in acute kidney injury. Nephron Exp Nephrol 109:e102-e107.
22. Maggini J, G Mirkin, I Bognanni, J Holmberg, IM Piazzon, I Nepomnaschy, H Costa, C Canones, S Raiden, M Vermeulen and JR Geffner. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5:e9252.
23. English K, FP Barry and BP Mahon. (2008). Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 115:50-58.
24. Kang JW, KS Kang, HC Koo, JR Park, EW Choi and YH Park. (2008). Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells. Stem Cells Dev 17:681-693.
25. Okunishi K, M Dohi, K Nakagome, R Tanaka, S Mizuno, K Matsumoto, J Miyazaki, T Nakamura and K Yamamoto. (2005). A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 175:4745-4753.
26. Daemen MA, C van 't Veer, G Denecker, VH Heemskerk, TG Wolfs, M Clauss, P Vandenabeele and WA Buurman. (1999). Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549.
27. Burst VR, M Gillis, F Putsch, R Herzog, JH Fischer, P Heid, J Muller-Ehmsen, K Schenk, JW Fries, CA Baldamus and T Benzing. (2010). Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol 114:e107-e116.
28. Duffield JS, S Hong, VS Vaidya, Y Lu, G Fredman, CN Serhan and JV Bonventre. (2006). Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 177:5902-5911.
29. Marcheselli VL, PK Mukherjee, M Arita, S Hong, R Antony, K Sheets, JW Winkler, NA Petasis, CN Serhan and NG Bazan. (2010). Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot Essent Fatty Acids 82:27-34.
30. Marcheselli VL, S Hong, WJ Lukiw, XH Tian, K Gronert, A Musto, M Hardy, JM Gimenez, N Chiang, CN Serhan and NG Bazan. (2003). Novel docosanoids inhibit brain ischemia- reperfusion-mediated leukocyte infiltration and proinflammatory gene expression. J Biol Chem 278:43807-43817.
31. Serhan CN, CB Clish, J Brannon, SP Colgan, N Chiang and K Gronert. (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192:1197-1204.
32. Hong S, E Tjonahen, EL Morgan, Y Lu, CN Serhan and AF Rowley. (2005). Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis. Prostaglandins Other Lipid Mediat 78:107-116.
33. Bazan HA, Y Lu, D Thoppil, TN Fitzgerald, S Hong and A Dardik. (2009). Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: implications for carotid interventions. Vascul Pharmacol 51:331-336.
34. Hassan IR and K Gronert. (2009). Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol 182:3223-3232.
35. Mukherjee PK, VL Marcheselli, CN Serhan and NG Bazan. (2004). Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101:8491-8496.
36. Zhao Y, F Calon, C Julien, JW Winkler, NA Petasis, WJ Lukiw and NG Bazan. (2011). Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretaseand PPARgamma-mediated mechanisms in Alzheimer's disease models. PLoS One 6:e15816.
37. Tian H, Y Lu, SP Shah and S Hong. (2011). 14S,21RDihy- droxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds. J Biol Chem 286:4443-4453.
38. Lu Y, H Tian and S Hong. (2010). Novel 14,21-dihydroxydocosahexaenoic acids: structures, formation pathways, and enhancement of wound healing. J Lipid Res 51:923-932.
39. Linden T, DM Katschinski, K Eckhardt, A Scheid, H Pagel and RH Wenger. (2003). The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis. Faseb J 17:761-763.
40. Goujon JM, T Hauet, E Menet, P Levillain, P Babin and M Carretier. (1999). Histological evaluation of proximal tubule cell injury in isolated perfused pig kidneys exposed to cold ischemia. J Surg Res 82:228-233.
41. Tirapelli LF, DF Barione, BF Trazzi, DP Tirapelli, PC Novas, CS Silva, M Martinez, RS Costa, S Tucci, Jr., et al. (2009). Comparison of two models for evaluation histopathology of experimental renal ischemia. Transplant Proc 41:4083-4087.
42. Nemeth K, A Leelahavanichkul, PS Yuen, B Mayer, A Parmelee, K Doi, PG Robey, K Leelahavanichkul, BH Koller, et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49.
43. Curtis LM, S Chen, B Chen, A Agarwal, CA Klug and PW Sanders. (2008). Contribution of intrarenal cells to cellular repair after acute kidney injury: subcapsular implantation technique. Am J Physiol Renal Physiol 295:F310-F314.
44. Luo L, J Lu, L Wei, D Long, JY Guo, J Shan, FS Li, PY Lu, PY Li and L Feng. (2010). The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 11:91.
45. Keyes KT, Y Ye, Y Lin, C Zhang, JR Perez-Polo, P Gjorstrup and Y Birnbaum. (2010). Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol 299:H153-H164.
46. Li M, AM Khan, JL Maderdrut, EE Simon and V Batuman. (2010). The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury. Am J Nephrol 32:522-532.
47. Rusai K, B Wagner, M Roos, C Schmaderer, M Strobl, KM Boini, A Grenz, D Kuhl, U Heemann, F Lang and J Lutz. (2009). The serum and glucocorticoid- regulated kinase 1 in hypoxic renal injury. Cell Physiol Biochem 24:577-584.
48. Pulkkanen KJ, MO Laukkanen, J Naarala and S Yla-Herttuala. (2000). False-positive apoptosis signal in mouse kidney and liver detected with TUNEL assay. Apoptosis 5:329-333.
49. Pasha Z, Y Wang, R Sheikh, D Zhang, T Zhao and M Ashraf. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134-142.
50. Tian H, Y Lu, SP Shah and S Hong. (2011). Autacoid 14S,21R- dihydroxydocosahexaenoic acid counteracts diabetic impairment on macrophage pro-healing functions. Am J Pathol [Epub ahead of print]; DOI: 10.1016/j.ajpath.2011.06.026.
51. Sadis C, G Teske, G Stokman, C Kubjak, N Claessen, F Moore, P Loi, B Diallo, L Barvais, M Goldman, S Florquin and A Le Moine. (2007). Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic antiinflammatory pathway. PLoS One 2:e469.
52. Hochheiser K, A Tittel and C Kurts. (2011). Kidney dendritic cells in acute and chronic renal disease. Int J Exp Pathol 92:193-201.
53. Eun LY, BW Song, MJ Cha, H Song, IK Kim, E Choi, W Chang, S Lim, EJ Choi, et al. (2010). Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium. Biochem Biophys Res Commun 402:272-279.
54. Franke TF, DR Kaplan and LC Cantley. (1997). PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437.
55. Brunet A, SR Datta and ME Greenberg. (2001). Transcriptiondependent and independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305.
56. Chen L, EE Tredget, PY Wu and Y Wu. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886.
57. Bussolati B, C Tetta and G Camussi. (2008). Contribution of stem cells to kidney repair. Am J Nephrol 28:813-822.
58. Tian H, Y Lu, SP Shah and S Hong. (2010). Novel 14S,21- dihydroxydocosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure. J Cell Biochem 111:266-273.
59. Humphreys BD, MT Valerius, A Kobayashi, JW Mugford, S Soeung, JS Duffield, AP McMahon and JV Bonventre. (2008). Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2:284-291.
60. Fang TC, MR Alison, HT Cook, R Jeffery, NA Wright and R Poulsom. (2005). Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 16:1723-1732.
61. Held PK, M Al-Dhalimy, H Willenbring, Y Akkari, S Jiang, Y Torimaru, S Olson, WH Fleming, M Finegold and M Grompe. (2006). In vivo genetic selection of renal proximal tubules. Mol Ther 13:49-58.
62. Ohtaki H, JH Ylostalo, JE Foraker, AP Robinson, RL Reger, S Shioda and DJ Prockop. (2008). Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A 105:14638-14643.
63. Choi H, RH Lee, N Bazhanov, JY Oh and DJ Prockop. (2011). Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-{kappa}B signaling in resident macrophages. Blood 118:330-338.
64. Jo SK, SA Sung, WY Cho, KJ Go and HK Kim. (2006). Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 21:1231-1239.
65. Manning BD and LC Cantley. (2007). AKT/PKB signaling: navigating downstream. Cell 129:1261-1274.
66. Matsui T, J Tao, F del Monte, KH Lee, L Li, M Picard, TL Force, TF Franke, RJ Hajjar and A Rosenzweig. (2001). Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330-335.
67. Mangi AA, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall and VJ Dzau. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201.
68. Meisel R, S Brockers, K Heseler, O Degistirici, H Bulle, C Woite, S Stuhlsatz, W Schwippert, M Jager, et al. (2011). Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3dioxygenase. Leukemia 25:648-654.
69. Chamberlain G, K Wright, A Rot, B Ashton and J Middleton. (2008). Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One 3:e2934.